Literature DB >> 35579481

Virtual management of hypertension: lessons from the COVID-19 pandemic-International Society of Hypertension position paper endorsed by the World Hypertension League and European Society of Hypertension.

Nadia A Khan1, George S Stergiou2, Stefano Omboni3,4, Kazuomi Kario5, Nicolas Renna6, Niamh Chapman7, Richard J McManus8, Bryan Williams9, Gianfranco Parati10, Aleksandra Konradi11, Shariful M Islam12, Hiroshi Itoh13, Ching S Mooi14, Bev B Green15, Myeong-Chan Cho16, Maciej Tomaszewski17,18.   

Abstract

The coronavirus disease 2019 pandemic caused an unprecedented shift from in person care to delivering healthcare remotely. To limit infectious spread, patients and providers rapidly adopted distant evaluation with online or telephone-based diagnosis and management of hypertension. It is likely that virtual care of chronic diseases including hypertension will continue in some form into the future. The purpose of the International Society of Hypertension's (ISH) position paper is to provide practical guidance on the virtual management of hypertension to improve its diagnosis and blood pressure control based on the currently available evidence and international experts' opinion for nonpregnant adults. Virtual care represents the provision of healthcare services at a distance with communication conducted between healthcare providers, healthcare users and their circle of care. This statement provides consensus guidance on: selecting blood pressure monitoring devices, accurate home blood pressure assessments, delivering patient education virtually, health behavior modification, medication adjustment and long-term virtual monitoring. We further provide recommendations on modalities for the virtual assessment and management of hypertension across the spectrum of resource availability and patient ability.
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2022        PMID: 35579481     DOI: 10.1097/HJH.0000000000003205

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.776


  2 in total

1.  Sleep and nocturnal hypertension: Genes, environment, and individual profiles.

Authors:  Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2022-08-09       Impact factor: 2.885

Review 2.  The first software as medical device of evidence-based hypertension digital therapeutics for clinical practice.

Authors:  Kazuomi Kario; Noriko Harada; Ayako Okura
Journal:  Hypertens Res       Date:  2022-10-07       Impact factor: 5.528

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.